Menu
D8 Holdings Corp. is a recently formed company whose business purpose is merger and acquisitions in the consumer sector. The company's objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement.
Vicarious Surgical Inc., a next-generation robotics technology company seeking to improve patient outcomes as well as both the
Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. Read why RBOT stock is a hold.
The Dow Jones closed lower by around 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company''s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga''s insider transactions platform. Container Store Group The Trade: The Container Store Group, Inc. (NYSE: TCS ) Chief Operating Officer Dhritiman Saha acquired a total of 5,000 shares an average price of $2.54. To acquire these shares, … Full story available on Benzinga.com
Vicarious Surgical Inc (NYSE: RBOT ) shares are trading lower by 8.5% to $0.87 Monday morning on downward momentum after the company last week priced a $45 million offering. What Else? Vicarious Surgical priced its underwritten public offering of 45 million shares of … Full story available on Benzinga.com
Bluejay Diagnostics (BJDX) +74%. Adamis Pharmaceuticals (ADMP) +59%. Aravive (ARAV) -71%. Vicarious Surgical (RBOT) -42%.
Virax Biolabs (NASDAQ: VRAX ) stock is on the rise Thursday as investors react to the news on an extension from the Nasdaq Exchange . According to a press release from the diagnostics test kits maker, the Nasdaq is giving it an additional 180 days to regain compliance. The company is currently trying to boost the price of its stock back above $1 per share to avoid delisting. This marks the second set of 180 days that Virax Biolabs has been given to regain compliance. The first was on Jan. 30, 2023. With this new notice, the company now has until Jan. 29, 2024, to regain compliance with Nasdaq listing standards. In order to regain compliance, Virax Biolabs has to do more than just get VRAX stock back above $1 per share. It has to do this and maintain a share price above that trading minimum for 10 consecutive business days. Who Will VRAX Stock Regain Compliance? Virax Biolabs hasn’t laid out plans for how it will boost its share price above the $1 minimum. One option the company may take is a reverse stock split.
Roku (NASDAQ: ROKU ) stock is sliding lower on Thursday after the streaming services shares were downgraded by Citi analyst Jason Bazinet . Bazinet dropped shares of ROKU stock from a “buy” rating to a “neutral” rating in a note to clients. For the record, the analysts’ consensus rating for ROKU shares is “hold” based on 26 opinions. To go with that downgrade, the Citi analyst increased his price target for ROKU stock from $75 per share to $100 per share. That represents a potential 9.6% upside from yesterday’s close. For perspective, the analysts’ consensus price prediction for ROKU is $75.88 per share. What’s Behind The ROKU Stock Downgrade? Here’s what Bazinet said about ROKU shares in a note to clients obtained by StreetInsider . “We see scope for Roku’s revenues to reaccelerate in 2024. However, given the run-up in the shares YTD (up ~120%), we believe this is largely priced into the equity. While both our estimates and target price move higher (the latter to $100 from $75), we are moving to the sidelines and downgrading Roku from Buy to Neutral.
Vicarious Surgical (NYSE: RBOT ) stock is falling on Thursday after the surgical robot company revealed details of a public offering . That public offering has Vicarious Surgical selling 45 million shares of RBOT stock at a price of $1 per share. Vicarious Surgical is expecting gross proceeds of $45 million from this stock offering. The company doesn’t say what it will do with these funds. There’s also an option for underwriters to acquire another 6.75 million shares within 30 days of the offering at that price. Morgan Stanley & Co. LLC and Cowen and Company, LLC are serving as joint book-running managers for the RBOT stock offering. What This Means For RBOT Stock A public stock offering means the total number of shares of RBOT stock is increasing. At that same time, this dilutes the stakes of investors currently holding the company’s shares. That helps explain why the stock is down today. Adding to that is the offering price of $1 per share. That’s below the prior closing price of $1.
